Page last updated: 2024-08-21

dronabinol and Chronic Motor and Vocal Tic Disorder

dronabinol has been researched along with Chronic Motor and Vocal Tic Disorder in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (10.53)18.2507
2000's7 (36.84)29.6817
2010's6 (31.58)24.3611
2020's4 (21.05)2.80

Authors

AuthorsStudies
Anavi-Goffer, S; Gorberg, V; McCaffery, P1
Aguirre Dávila, L; Guizzaro, L; Koch, A; Lasch, F; Müller-Vahl, K1
Bloch, MH; Johnson, JA; Landeros-Weisenberger, A; Leckman, JF1
Lobsien, E; Schwittay, MA; Steinbrecher, A1
Jakubovski, E; Müller-Vahl, K1
Kawohl, W; Pichler, EM; Roser, P; Seifritz, E1
Bird, R; Evans, L; Trainor, D1
Clarke, CE; Curtis, A; Rickards, HE1
Falkai, P; Hasan, A; Münchau, A; Roessner, V; Rothenberger, A; Wobrock, T1
Müller-Vahl, KR2
Brandauer, E; Ennemoser, O; Ertl, M; Giacomuzzi, SM; Golaszewski, S; Hinterhuber, H; Riemer, Y; Rössler, H1
Emrich, HM; Kolbe, H; Müller-Vahl, KR; Prevedel, H; Schneider, U; Theloe, K1
Daldrup, T; Emrich, HM; Kolbe, H; Müller-Vahl, KR; Prevedel, H; Schneider, U; Theloe, K1
Berding, G; Brooks, DJ; Buchert, R; Donnerstag, F; Emrich, HM; Fitschen, J; Gielow, P; Harke, H; Hofmann, M; Knapp, WH; Knoop, BO; Müller-Vahl, K; Schneider, U; Stuhrmann, M1
Emrich, HM; Kolbe, H; Müller-Vahl, KR; Schneider, U1
Emrich, HM; Jöbges, M; Koblenz, A; Kolbe, H; Müller-Vahl, KR; Schneider, U1
Daldrup, T; Emrich, HM; Jöbges, M; Koblenz, A; Kolbe, H; Müller-Vahl, KR; Schneider, U1

Reviews

3 review(s) available for dronabinol and Chronic Motor and Vocal Tic Disorder

ArticleYear
Cannabinoids for Tourette's Syndrome.
    The Cochrane database of systematic reviews, 2009, Oct-07, Issue:4

    Topics: Cannabinoids; Dronabinol; Humans; Randomized Controlled Trials as Topic; Tourette Syndrome

2009
[Outlines of interdisciplinary addiction research given by the example of medical imaging with PET, SPECT and fMRI regarding effects of psychotropic substances].
    Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater, 2010, Volume: 24, Issue:4

    Topics: Animals; Brain; Cocaine; Cocaine-Related Disorders; Cognition; Cooperative Behavior; Dose-Response Relationship, Drug; Dronabinol; Emotions; Humans; Interdisciplinary Communication; Magnetic Resonance Imaging; Marijuana Abuse; Perception; Positron-Emission Tomography; Regional Blood Flow; Tomography, Emission-Computed, Single-Photon; Tourette Syndrome

2010
Treatment of Tourette syndrome with cannabinoids.
    Behavioural neurology, 2013, Volume: 27, Issue:1

    Topics: Dronabinol; Humans; Psychotropic Drugs; Tourette Syndrome

2013

Trials

6 trial(s) available for dronabinol and Chronic Motor and Vocal Tic Disorder

ArticleYear
A Phase-2 Pilot Study of a Therapeutic Combination of Δ
    The Journal of neuropsychiatry and clinical neurosciences, 2021,Fall, Volume: 33, Issue:4

    Topics: Adult; Amides; Cannabinoid Receptor Agonists; Double-Blind Method; Dronabinol; Ethanolamines; Female; Humans; Male; Palmitic Acids; Pilot Projects; Psychiatric Status Rating Scales; Severity of Illness Index; Tourette Syndrome; Treatment Outcome

2021
Treatment of Tourette syndrome with delta-9-tetrahydrocannabinol (delta 9-THC): no influence on neuropsychological performance.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2003, Volume: 28, Issue:2

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Prospective Studies; Statistics, Nonparametric; Tourette Syndrome

2003
Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial.
    The Journal of clinical psychiatry, 2003, Volume: 64, Issue:4

    Topics: Adolescent; Adult; Double-Blind Method; Dronabinol; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Placebos; Psychiatric Status Rating Scales; Receptors, Cannabinoid; Receptors, Drug; Severity of Illness Index; Tics; Tourette Syndrome; Treatment Outcome

2003
Treatment of Tourette's syndrome with delta-9-tetrahydrocannabinol.
    The American journal of psychiatry, 1999, Volume: 156, Issue:3

    Topics: Adult; Dronabinol; Humans; Male; Severity of Illness Index; Tourette Syndrome; Treatment Outcome

1999
Influence of treatment of Tourette syndrome with delta9-tetrahydrocannabinol (delta9-THC) on neuropsychological performance.
    Pharmacopsychiatry, 2001, Volume: 34, Issue:1

    Topics: Adolescent; Adult; Aged; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Hallucinogens; Humans; Male; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Tourette Syndrome

2001
Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.
    Pharmacopsychiatry, 2002, Volume: 35, Issue:2

    Topics: Adolescent; Adult; Aged; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Tics; Tourette Syndrome; Treatment Outcome

2002

Other Studies

10 other study(ies) available for dronabinol and Chronic Motor and Vocal Tic Disorder

ArticleYear
Different responses of repetitive behaviours in juvenile and young adult mice to Δ
    British journal of pharmacology, 2021, Volume: 178, Issue:3

    Topics: Animals; Cannabidiol; Child; Decision Making; Dronabinol; Humans; Medical Marijuana; Mice; Tourette Syndrome

2021
Potential impact of COVID-19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA-TICS study.
    Pharmaceutical statistics, 2021, Volume: 20, Issue:3

    Topics: Cannabidiol; Computer Simulation; COVID-19; Data Interpretation, Statistical; Dronabinol; Drug Combinations; Endpoint Determination; Humans; Mental Health; Physical Distancing; Randomized Controlled Trials as Topic; Research Design; Sample Size; Severity of Illness Index; Tic Disorders; Tics; Time Factors; Tourette Syndrome; Treatment Outcome

2021
Tic Reduction in Adult Onset Gilles De La Tourette Syndrome Using as Required Nabiximols Spray.
    Tremor and other hyperkinetic movements (New York, N.Y.), 2021, Volume: 11

    Topics: Adult; Cannabidiol; Dronabinol; Drug Combinations; Humans; Male; Tics; Tourette Syndrome

2021
Speechlessness in Gilles de la Tourette Syndrome: Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients.
    International journal of molecular sciences, 2017, Aug-10, Volume: 18, Issue:8

    Topics: Adolescent; Adult; Cannabinoid Receptor Agonists; Dronabinol; Humans; Male; Medical Marijuana; Severity of Illness Index; Tics; Tourette Syndrome; Young Adult

2017
Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report.
    International journal of psychiatry in medicine, 2019, Volume: 54, Issue:2

    Topics: Adolescent; Cannabidiol; Cannabinoid Receptor Modulators; Dronabinol; Drug Therapy, Combination; Female; Humans; Tourette Syndrome

2019
Severe motor and vocal tics controlled with Sativex®.
    Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2016, Volume: 24, Issue:6

    Topics: Adult; Cannabidiol; Dronabinol; Drug Combinations; Humans; Male; Psychiatric Status Rating Scales; Reproducibility of Results; Severity of Illness Index; Tics; Tourette Syndrome; Treatment Outcome; Videotape Recording

2016
Oral delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: a case report.
    Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:2

    Topics: Administration, Oral; Adolescent; Cerebral Cortex; Dronabinol; Humans; Male; Neural Inhibition; Tourette Syndrome; Transcranial Magnetic Stimulation

2010
Tourette's syndrome.
    Current topics in behavioral neurosciences, 2009, Volume: 1

    Topics: Adolescent; Adult; Aged; Brain; Cannabinoid Receptor Modulators; Dronabinol; Female; Humans; Iodine Isotopes; Male; Middle Aged; Morpholines; Pyrazoles; Randomized Controlled Trials as Topic; Receptor, Cannabinoid, CB1; Tomography, Emission-Computed, Single-Photon; Tourette Syndrome; Young Adult

2009
[123I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB1 receptors before and after Delta9-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in tourette patients.
    Biological psychiatry, 2004, May-01, Volume: 55, Issue:9

    Topics: Adult; Brain; Chromatography, Thin Layer; Dronabinol; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Psychotropic Drugs; Radiation Dosage; Radiopharmaceuticals; Receptor, Cannabinoid, CB1; Time Factors; Tomography, Emission-Computed, Single-Photon; Tourette Syndrome; Whole Body Imaging

2004
THC for Tourette's syndrome.
    The Harvard mental health letter, 1999, Volume: 16, Issue:5

    Topics: Adult; Dronabinol; Humans; Male; Marijuana Smoking; Obsessive-Compulsive Disorder; Tourette Syndrome

1999